Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
RSS SUMMARY · AGGREGATED FROM CNBC
U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.
U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.
U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Finland’s president says EU should expand to 40 states — including Canada
CNBC·1h ago·3 min read
Health
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
CNBC·23m ago·3 min read
US
Amazon engineers in Seattle slam employer for building AI data centers while laying off 30,000 staffers
CNBC·6h ago·3 min read
US
Elon Musk’s net worth poised to sail past $1 trillion in SpaceX IPO
CNBC·7h ago·3 min read
Related
On this beat
Health
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
CNBC·23m ago·3 min read
Health
An Uncertain Path for Americans Exposed to Ebola
TNYT·10h ago·3 min read
Health
Autism therapy has attracted predatory providers who bill for phantom services, pad hours and charge steep fees for care delivered by low-paid workers. Here are five takeaways from a WSJ investigation
TWSJ·14h ago·3 min read
Health
New research could help doctors tweak anesthesia to more resemble natural sleep, reducing risks
TWSJ·14h ago·3 min read